Get Your Teen Ready for a Summer Job with Lifeguarding Classes at UC Campus Recreation
This February and March, the Campus Recreation Center is offering the American Red Cross (ARC) Lifeguard Training Course. Since ARC certifications are recognized across the nation, those who complete the course can work anywhere in the country.
Course dates:
- Feb. 27 and March 6, 5 - 8:30 p.m.
- Feb. 28 and March 7, 9 a.m. - 5 p.m.
- March 1 and March 8, 10 a.m. - 4 p.m.
In accordance with ARC standards,
attendance at all six class dates (listed above) is mandatory
and participants must be at least 15 years old by the last day of class.
A skills pretest is required and will occur at 5 p.m. on Feb. 27.
According to Carol Wolkoff, aquatics assistant director at Campus Recreation, UCs American Red Cross training course participants who successfully complete the program will be certified in First Aid, Lifeguarding, CPR and AED use for two years. Any teenager, at least 15 years old by the last day of class on March 8, can sign up.
The lifeguard certification class will take place over two weekends at a very reasonable rate," said Wolkoff. "Other locations charge up to $100 more than our non-member price.
Call 513-556-0604 or stop by the Member Services desk at the Campus Recreation to register.
Find more aquatics class information on the Campus Recreation
.
Related Stories
Get to know CCM’s newest faculty and staff members
September 2, 2026
UC’s College-Conservatory of Music will welcome a variety of new faculty and staff members to its roster of distinguished performing and media arts experts, researchers and educators this fall.
How two UC co-ops joined Procter & Gamble for fast-track innovation
September 2, 2026
University of Cincinnati cooperative learning students observed a real-world creative workshop with Procter & Gamble on an early-stage product.
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.